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Summary 
TLR8 is among the highest-expressed pattern-recognition receptors in the human myeloid 
compartment, yet its mode of action is poorly understood. TLR8 engages two distinct ligand 
binding sites to sense RNA degradation products, although it remains unclear how these 
ligands are formed in cellulo in the context of complex RNA molecule sensing. Here, we 
identified the lysosomal endoribonuclease RNase T2 as a non-redundant upstream 
component of TLR8-dependent RNA recognition. RNase T2 activity is required for rendering 
complex single-stranded, exogenous RNA molecules detectable for TLR8. This is due to RNase 
T2’s preferential cleavage of single-stranded RNA molecules between purine and uridine 
residues, which critically contributes to the supply of catabolic uridine and the generation of 
purine-2′,3′-cyclophosphate-terminated oligoribonucleotides. Thus-generated molecules 
constitute agonistic ligands for the first and second binding pocket of TLR8. Together, these 
results establish the identity and origin of the RNA-derived molecular pattern sensed by TLR8. 
Introduction 
Pattern-recognition receptors (PRRs) of the innate branch of our immune system have evolved 
to sense the presence of microbe-associated molecular patterns (MAMPs) as non-self. A 
heterogeneous group of PRRs can detect microbial nucleic acids in different subcellular 
compartments (Barbalat et al., 2011, Wu and Chen, 2014). Microbe-derived nucleic acids do 
not always fulfill the criteria of a true MAMP given that they do not necessarily differ in their 
biochemical structure from host-derived nucleic acids. Here, to ensure discrimination of self 
versus non-self, additional principles apply (Roers et al., 2016). These principles include the 
following: the positioning of these PRRs in compartments that are devoid of potential self-
ligands (e.g., the endolysosome), the regulation of the abundance of endogenous nucleic acids 
(e.g., by nucleases), and the modulation of nucleic acid sensors’ thresholds by additional 
licensing signals (e.g., type I interferons). Among the toll-like-receptor (TLR) family, four TLRs 
detect nucleic acids in the human system: TLR3 senses long double-stranded RNA (dsRNA), 
and TLR9 detects CpG-motif-containing DNA molecules, whereas TLR7 and TLR8 sense RNA 
degradation products. Mice express TLR13 as an additional nucleic-acid-sensing TLR. 
Interestingly, this TLR seems to respond to single-stranded RNAs (ssRNAs) of a rather specific 
sequence and conformation, which renders it unique among the other nucleic-acid-sensing 
TLRs that seem to harbor little sequence specificity (Song et al., 2015). 
The role of TLR7 has been extensively studied in the murine system. Here, it has been shown 
that TLR7 plays a pivotal role in virus recognition and sterile inflammation (Barbalat et al., 
2011). Human and murine TLR7 are well expressed in plasmacytoid dendritic cells (pDCs) and 
B cells, as well as in certain cells of the myeloid lineage. Human TLR8, on the other hand, is 
not expressed in pDCs or B cells but is highly abundant in cells of the myeloid lineage, including 
neutrophils. Although the expression profile of murine TLR8 is similar to that of human TLR8, 
it differs in functionality. TLR7-deficient mouse macrophages display a complete loss of 
responsiveness toward ssRNA molecules or synthetic agonists that activate human TLR7 or 
TLR8 (Diebold et al., 2004, Heil et al., 2004). Although studies have reported on the 
functionality of murine TLR8 under certain conditions, it appears that murine TLR13 acts as a 
functional homolog of human TLR8 (Krüger et al., 2015, Oldenburg et al., 2012). As such, it has 
been shown that bacteria and bacterial RNA of various sources are potent activators of hTLR8 
and mTLR13, respectively. However, despite these functional commonalities, the modes of 
recognition between these two TLRs are vastly different (Song et al., 2015, Tanji et al., 2015). 
With regard to their ligand-sensing capacities, both human TLR7 and TLR8 share a similar 
mode of action. Their horseshoe-shaped leucine-rich-repeat (LRR) domains form side-to-side 
homodimers in a rotational symmetry. In this configuration, two distinct sets of ligand-binding 
locations are available (Tanji et al., 2015, Zhang et al., 2016, Zhang et al., 2018). Two ligand 
binding pockets, one provided by each protomer, are situated at the apex of the dimerization 
interface (first binding pocket). For TLR8, this site has been shown to bind uridine molecules, 
as well as synthetic TLR8 agonists such as TL8-506. Two additional binding pockets, again one 
from each protomer, are positioned at the concave surface of the LRRs (second binding 
pocket). This pocket has been shown to bind short oligoribonucleotides, whereas its 
engagement strongly increases the affinity of the first binding pocket toward uridine 
molecules. As such, optimal TLR8 agonism is achieved when the first and second binding 
pockets are occupied. Of note, synthetic agonists and high concentrations of uridine can exert 
TLR8 agonism in the absence of the engagement of second binding pocket (Tanji et al., 2015). 
However, to exert agonistic activity, complex RNA ligands require a functional second binding 
pocket. Despite our detailed structural understanding of the TLR8 ligand-binding domains, it 
has yet remained elusive how TLR8-agonistic ligands are being formed in the context of 
sensing complex RNA ligands. In this study, we set out to explore the mechanism by which 
complex RNA molecules and live pathogens are rendered “visible” to TLR8. 
Results 
TLR7 and TLR8 Are Functional TLRs in BLaER1 Monocytes 
To genetically dissect TLR8 signaling, we turned to the BLaER1 system that we have previously 
employed to model human monocytes (Gaidt et al., 2017, Gaidt et al., 2016). In these 
cells, TLR8 expression is strongly upregulated upon transdifferentiation (Figure S1A). We used 
the well-established RNA40 molecule, which is a 20-mer ssRNA oligonucleotide (ON) derived 
from the HIV-1 genome (Heil et al., 2004), as a prototypic ligand. We used a variant of RNA40 
stabilized by phosphorothioate modifications, designated as RNA40S. This modification 
renders the inter-nucleotide linkage more nuclease resistant and hence increases the half-life 
of this ON in biological systems. To deliver RNA into endolysosomal compartments, we used 
the polycationic polypeptide poly-L-arginine (pR) (Ablasser et al., 2009). As a proxy of pro-
inflammatory gene expression, we measured IL-6 production. After stimulation with RNA40S 
or with small-molecule ligands specific to TLR8 (TL8-506) or to both TLR7 and TLR8 (R848), 
BLaER1 monocytes produced IL-6 (Figure 1A). As expected, TLR8−/− BLaER1 monocytes were 
unresponsive to the TLR8-specific ligand TL8-506, whereas R848-mediated activation was only 
blunted when both TLR7 and TLR8 were ablated. On the other hand, RNA40S-mediated IL-6 
production was completely TLR8 dependent (Figures 1B and 1C). TLR4-dependent stimulation 
(LPS) was active in all genotypes tested. TLR8 activation was observed when increasing doses 
of RNA were used and was also seen when RNA40S was transfected with Lipofectamine 2000, 
albeit at lower activity (Figure 1D and Figure S1B). Studying the phosphodiester version of 
RNA40 (RNA40°) also showed TLR8-dependent stimulation but with lower potency 
(Figure S1C). Similar results were obtained when an unrelated phosphodiester ssRNA ON (P20-
5M) was studied (Figure S1D). Control BLaER1 monocytes produced IL-6 in response to this 
ON, whereas TLR8−/− cells showed no response. As previously noted, a self-complementary 
version of this ON (P20) did not exert any TLR8-agonistic activity (Ablasser et al., 2009), 
corroborating the notion that a certain degree of single-strand conformation was required for 
stimulating this TLR. Altogether, these results establish that BLaER1 monocytes serve as a 
physiological model for the study of RNA-dependent activation of TLR8. 
 
Figure 1: TLR7 and TLR8 Are Functional TLRs in BLaER1 Monocytes. (A and B) BLaER1 monocytes of indicated 
genotypes were stimulated with (A) TL8-506, R848, and LPS or were (B) unstimulated or stimulated with pR and 
RNA40S. After 14 h, IL-6 release was measured. (C) TLR8 expression in BLaER1 cells of indicated genotypes.(D) 
Control and TLR8-deficient BLaER1 monocytes were stimulated with increasing amounts of RNA40S. After 14 h, 
IL-6 was measured.Data are depicted as mean + SEM of three independent experiments (A, B, and D) or one of 
three representative blots (C). Statistics indicate significance by two-way ANOVA: ∗∗∗p ≤ 0.001; ∗∗p ≤ 0.01; ∗p ≤ 
0.05; ns, not significant. See also Figure S1. 
RNase-T2-Deficient Cells Fail to Respond to RNA Oligonucleotides 
We hypothesized that luminal RNases must function upstream of TLR8 in that they degrade 
RNA40 into ligands that engage its first and/or second binding pocket. We thus considered 
annotated enzymes with ribonuclease activity to be located either in the lysosome or in the 
extracellular space. Prioritizing lysosomal RNases that are well expressed in both primary 
human monocytes and transdifferentiated BLaER1 monocytes, we first focused on RNASE2, 
RNASE6, and RNASET2. We additionally included RNASE1 because of its high expression in 
BLaER1 cells (Figure 2A). Studying knockout cell lines of these RNases indicated that 
RNASET2−/− cells, but not RNASE1−/−, RNASE2−/−, or RNASE6−/− cells, displayed a complete loss-
of-function phenotype upon RNA40S stimulation (Figure 2B and Figures S2A–S2C). Of note, 
RNase T2 deficiency had no impact upon TLR4-mediated IL-6 production, and stimulation with 
synthetic TLR8 agonists was unaffected in the absence of this RNase. This indicates that RNase 
T2 deficiency has no impact on the functionality of this receptor per se. Analogous results 
were obtained when we studied human monocytic THP-1 cells deficient for RNase T2 or TLR8 
(Figure S2D). Reconstitution of RNase T2 by lentiviral transduction rescued RNASET2−/− cells in 
their response toward RNA40S in a dose-dependent fashion (Figures 2C and 2D). Finally, 
phosphodiester-linked ONs were also completely dependent on RNase T2 in their TLR8-
stimulatory activity (Figure S2E). In summary, these results suggest that RNase T2 is non-
redundantly required for rendering RNA ONs TLR8 agonistic. 
 
Figure 2: RNase-T2-Deficient Cells Fail to Respond to RNA Oligonucleotides. (A) Venn diagram of proteins that 
are, according to their Gene Ontology (GO) terms, annotated as “lysosomal,” “extracellular space,” or 
“ribonuclease activity” (left). A heatmap shows RNA expression levels of several RNases and their GO-term 
designation in the indicated cell types (middle and right). (B) IL-6 production in BLaER1 Controls and RNASET2−/− 
cells stimulated with RNA40S, TL8-506, R848, and LPS for 14 h. (C) RNASET2−/− cells were reconstituted with 
doxycycline-inducible RNase T2 (++, 1 μg/mL; +, 0.5 μg/mL). An inducible mScarlet construct was used as a 
control. (D) The immunoblot corresponding to the reconstitution experiment is shown. The asterisk indicates 
unspecific bands. Data are depicted as mean + SEM of three independent experiments or one of three 
representative blots. Statistics indicate significance by two-way ANOVA: ∗∗∗p ≤ 0.001; ∗∗p ≤ 0.01; ∗p ≤ 0.05; ns, not 
significant. See also Figure S2. 
RNase T2 Cleaves RNA between Purine Bases and Uridine 
We considered it most likely that RNase T2 degrades RNA into fragments that are rendered 
agonistic for either the first and/or second binding pocket of TLR8. To characterize the 
putative degradation pattern of RNase-T2-digested RNA40, we incubated RNA40S by using 
recombinant RNase T2 at limiting enzyme concentrations. This provided a characteristic 
cleavage pattern that was different from the one obtained with bovine pancreatic RNase A, 
which is orthologous to human RNase 1 (Figures 3A and 3B). To further analyze the cleavage 
pattern of RNase-T2-digested RNA40, we analyzed individual fragments identified by liquid 
chromatography (LC) by using MALDI-TOF (Figure 3C). Here, we first studied the digestion of 
RNA40° because RNA40S-derived fragments generated less-defined peaks on LC as a result of 
the diastereomeric configuration of their phosphorothioate bonds. These analyses revealed 
at least nine distinct peaks, of which eight peaks could be assigned to distinct masses 
compatible with endoribonuclease cleavage products of RNA40°. Interestingly, all of the 
identified cleavage products were consistent with endoribonuclease activity between a 
guanosine and uridine residue (Figure 3D). Moreover, the majority of the identified fragments 
displayed a mass that was compatible with a 3′ configuration of a 2′,3′-cyclophosphate rather 
than a 3′ phosphate (Figure 3E). Conducting analogous experiments with RNA40S provided 
comparable results. As such, a similar cleavage pattern was observed with fragments 
consistent with endoribonuclease activity between guanosine and uridine (GU). Moreover, 
the mass of the individual fragments indicated the presence of a 2′,3′-cyclophosphate 
configuration (Figures S3A and S3B). In total, analyzing RNase-T2-digested RNA40 molecules 
yielded 11 out of 14 possible fragments that were consistent with cleavage between GU 
(Figure S3C). In line with the well-established notion that RNase A cleaves after pyrimidines, 
RNA40° digested with RNase A generated fragments that were terminated by a 3′ uridine or 
cytidine (Figure 3F). As observed for RNase T2, the masses of the fragments were consistent 
with a 2′,3′-cyclophosphate configuration. Because RNA40 provided limited sequence space 
for systematic exploration of the substrate specificity of RNase T2, we next conducted 
RNase T2 cleavage assays by using a set of ONs that contained all 16 possible dinucleotide 
substrates (Figures 3G and 3H). These experiments confirmed that RNase T2 cleaved between 
GU and furthermore indicated that also AU served as a substrate with comparable efficiency. 
Of note, treating the self-complementary oligoribonucleotide P20 with RNase T2 did not yield 
any discernable fragments, whereas its ssRNA counterpart was readily digested (Figure S3D). 
These results indicate that base-pairing RNA molecules did not serve as substrates for RNase 
T2, providing a rationale as to why such oligoribonucleotides exerted no TLR8 activity 
(Figure S1D) (Ablasser et al., 2009). In summary, these results indicate that, under the 
conditions tested, RNase T2 preferentially cleaves ssRNA between purine and uridine residues 
and leaves a guanosine or adenosine 2′,3′-cyclophosphate configuration. 
 
Figure 3: RNase T2 Cleaves RNA between Purine Bases and Uridine. (A and B) Urea gel of RNA40S digested with 
decreasing RNase T2 (A) or RNase A (B) concentrations. One representative gel of two independent experiments 
is shown. (C) HPLC chromatogram of RNA40°-derived ON fragments (left; fragment masses determined by 
MALDI-TOF) and the corresponding MALDI peak of one representative peak (right). (D) RNA40° was digested with 
RNase T2 and analyzed by HPLC and MALDI-TOF. The most likely assigned fragments based on MALDI-TOF 
analysis are depicted next to all calculated and found masses. Calculated masses are shown as [M-H]−. (E) 
Structure of mononucleotide 2′,3′-cyclophosphates (left) and Mononucleotide 3′-phosphates (right). (F) RNA40° 
was digested in vitro with RNase A and analyzed as above. Masses are shown as [M-H]−. (G) 16 ONs containing 
all possible dinucleotide combinations (A4NNA2) were analyzed after RNase T2 in vitro digestion. Of note, all ONs 
with a U at the B1 site were also cut between A and U, whereas cleavage between U and N was not detected. (H) 
HPLC chromatograms corresponding to the in vitro digests of GU, GG, AU, and AA (G). See also Figure S3. 
Altered RNA Catabolism In Cellulo in the Absence of RNase T2 
To address how RNase T2 affects the catabolism of RNA substrates in cellulo, we undertook a 
mass spectrometry approach to determine the abundance of selected metabolites in control 
and RNASET2−/− cells (Figure 4A). On the basis of synthetic standards, in vitro digests of RNA40, 
or unequivocally ascribable masses, we could employ this technology to determine selected 
metabolites ranging from nucleosides up to certain trinucleotides. We first aimed at 
identifying RNA40S-derived degradation products by taking advantage of the fact that RNA40S-
derived nucleotides are distinguishable by mass from endogenous molecules because the 
sulfur atom is present as part of the phosphodiester linkage. Analyzing mono- and 
dinucleotides with a 2′,3′-cyclophosphate moiety showed that the abundance of RNA40S-
derived C>p and CC>p was only scarcely affected by RNase T2 deficiency, whereas the levels 
of G>p were reduced by more than 90% (Figure 4B). Of note, U>p and UU>p levels were also 
greatly reduced in the absence of RNase T2. RNA40S-derived A>p was undetectable in control 
and RNase-T2-deficient samples. Moreover, GG>p and AA>p, which are not present in RNA40, 
were not found in any sample. Intriguingly, peaks assignable to RNA40S-derived UG>p or 
UUG>p were readily identified in control cells but were only scarcely detectable or 
undetectable in the lysates of RNase-T2-deficient cells. Analyzing the endogenous pool of 
nucleotides (non-sulfur-containing nucleotides) in these RNA40-stimulated samples 
(Figure 4C) or unstimulated samples (Figure S4A) largely mirrored the results obtained with 
the RNA40S-derived metabolites. Endogenous C>p and CC>p levels were not affected by RNase 
T2 deficiency, whereas G>p, U>p, and UU>p levels strongly decreased. In addition, 
endogenous A>p, AA>p, and GG>p levels could now be detected, and these metabolites were 
also strongly affected by the absence of RNase T2. Of note, mononucleoside levels were not 
decreased in RNASET2−/− cells (Figure 4C and Figure S4A). Although these results could provide 
unequivocal proof of the source of the measured metabolites and also inform on the relative 
abundance of these metabolites dependent on RNase T2, these experiments cannot provide 
insight into the relative increase in putative RNA40-derived metabolites upon RNA40 
stimulation. To address this question, we conducted stimulation experiments with RNA40°, 
which gives rise to degradation products that are of the same mass as the endogenous 
metabolites. These experiments revealed that RNA40° stimulation led to a moderate increase 
in G>p, A>p, U>p, and C>p levels (2.8-, 1.5-, 3.4-, and 1.9-fold, respectively) and that G>p and 
A>p levels, and to a lesser extent U>p levels, were RNase T2 dependent (Figure 4D). GG>p, 
AA>p, UU>p, and CC>p levels were not increased upon RNA40 stimulation, and similarly to the 
mononucleotides, AA>p, GG>p, and to a lesser extent UU>p levels were RNase T2 dependent. 
C>p and CC>p levels were unaffected by RNase T2 deficiency. Intriguingly, UG>p levels were 
induced by 33-fold upon RNA40 stimulation, and UUG>p could only be detected in RNA40-
stimulated cells. Both these metabolites were completely RNase T2 dependent. Of note, 
RNASE2- and RNASE6-deficient cells showed no decrease in RNA40-derived metabolites. A 
reduction of C>p and CC>p levels was observed only for RNASE1−/− cells (Figures S4B–S4D). In 
conclusion, these results indicate that RNase T2 is non-redundantly necessary for generating 
certain ribonucleotides with a 2′,3′-cyclophosphate moiety of both endogenous and 
exogenous origins. Most critically, UG>p and UUG>p were completely RNase-T2-dependent 
metabolites and almost exclusively seen in cells stimulated with exogenous RNA. 
 
Figure 4: RNase T2 Deficiency Leads to Altered RNA Metabolism. (A) BLaER1 cells were stimulated with RNA40S 
for 14 h, and then lysates were analyzed by liquid chromatography-mass spectrometry (LC-MS). (B and C) Cell 
lysates of RNA40S stimulated BLaER1 cells with indicated genotypes were analyzed by LC-MS. RNA40S-derived (B) 
or endogenous (C) metabolites are shown. Data are normalized to control cells (note logarithmic scale). (D) Cell 
lysates of RNA40°-stimulated BLaER1 cells with indicated genotypes were analyzed by LC-MS. For each 
metabolite dataset, the mean of the maximal values was determined, and all data are depicted as a fraction 
thereof. Data are depicted as mean + SEM of three independent experiments. Statistics indicate significance by 
a Welch’s unequal variances t test (B and C) or by one-way ANOVA (D). ∗∗∗∗p ≤ 0.0001; ∗∗∗p ≤ 0.001; ∗∗p ≤ 0.01; ∗p 
≤ 0.05; ns, not significant; n.d., not detected. See also Figure S4. 
A Minimal Motif for TLR8 
The above studies implied that the presence of a GU dinucleotide, which serves as a 
recognition site for RNase T2, was important for the TLR8 agonistic activity of RNA40. Given 
that RNA40 contains four such GU dinucleotides, we turned to a more reductionist setting to 
address this hypothesis. Indeed, previous work showed that a UUGU motif within an 
otherwise non-stimulatory deoxy ON exerted pro-inflammatory activity in human myeloid 
cells, consistent with TLR8 stimulation (Forsbach et al., 2008). We hypothesized that the 
activity of this motif was dictated by the presence of its GU dinucleotide, which serves as a 
substrate for RNase T2. Indeed, testing the UUGU-containing ON, we observed its activity to 
be dependent on RNase T2 and TLR8, albeit with lower activity than RNA40 (Figure 5A). 
Moreover, in line with the substrate specificity of RNase T2, exchanging the terminal uridine 
in this motif for the other three naturally occurring ribonucleotides, we observed that uridine, 
but not any other nucleotide following guanosine, was critically required for rendering this 
motif stimulatory for TLR8 (Figure 5A). Interestingly, in this previous study, AU-rich ONs were 
also reported to exert pro-inflammatory activity. Again, these observations are in line with the 
observed substrate specificity of RNase T2 and raise the question as to whether AU-containing 
oligoribonucleotides exert RNase-T2-dependent TLR8 agonism. Indeed, UUAU stimulated 
RNase-T2-dependent TLR8, and when the AU motif was permutated to AA (UUAA), no 
stimulatory activity was observed (Figure 5B). These functional data were reflected by the 
abundance of respective ON-dependent metabolites in cellulo: only UUGU, but not UUGA-
stimulated, cells displayed an increase in G>p and UG>p levels, and this was completely RNase 
T2 dependent (Figure 5C). At the same time, UUAU, but not UUAA, stimulation led to an 
RNase-T2-dependent increase in A>p and UA>p levels. Interestingly, U>p levels were 
disconnected from the stimulatory capacity of these ONs. To this end, the non-stimulatory ON 
UUAA led to the same levels of U>p as the agonistic ON UUGU, whereas these levels were 
largely RNase T2 independent. In summary, these data suggest that UURU constitutes a 
minimal motif for RNase-T2-dependent TLR8 activation by an RNA ON. Moreover, these 
results indicate that the RNase-T2-dependent release of UR>p fragments highly correlates 
with TLR8 agonistic activity, although a sole increase in U>p levels in the context of RNA 
stimulation is not sufficient for TLR8 agonism. 
 
Figure 5: A Minimal Motif for TLR8. (A and B) BLaER1 cells were stimulated with the indicated DNA-RNA UUG-
containing (A) or UUA-containing (B) hybrid ONs or control stimuli. The four bases in the middle are 
ribonucleotides flanked by random deoxynucleotides (dN). IL-6 was measured after 14 h. (C) BLaER1 cells were 
stimulated with the indicated DNA-RNA hybrid ONs and analyzed by LC-MS (14 h after stimulation). For all 
stimulations, 2.4 μg of the respective ON was used. For each metabolite dataset, the mean of the maximal values 
was determined, and all data are depicted as a fraction thereof. Data are depicted as mean + SEM of three 
independent experiments. Statistics indicate significance by two-way (A and B) or one-way ANOVA (C): ∗∗∗∗p ≤ 
0.0001; ∗∗∗p ≤ 0.001; ∗∗p ≤ 0.01; ∗p ≤ 0.05; ns, not significant. See also Figure S5. 
  
RNase T2 Degradation Products Bypass the Lack of RNase T2 to Exert TLR8 Agonism 
We hypothesized that RNase T2 activity acting on exogenous RNA substrates was 
predominantly required for generating ligands for the second binding pocket of TLR8. This idea 
was spurred by the notion that previous structural studies had revealed the coordination of a 
YG or YYG di- or trinucleotide with a 2′,3′-cyclophosphate in the second binding pocket of TLR8 
(Figure S5A). The requirement for this (Y)YG>p motif in this binding location—as revealed in 
these studies—was well in line with the notion that stimulation with TLR8-agonistic ONs 
resulted in the appearance of such fragments in an RNase-T2-dependent manner (Figure 5C). 
To address whether we could directly engage TLR8 by providing agonists for the second 
binding pocket of TLR8, we digested RNA40S by using RNase T2 in vitro by using limiting 
amounts of enzyme (Figures 6A and 6B) and subsequently delivered the thus-obtained 
fragments into BLaER1 monocytes. At the same time, we treated RNA40S by using RNase A 
(Figure 6B), covering a range of three concentrations to encompass both excess (+++) and 
limiting (+) enzyme amounts. As expected, undigested RNA40 was only active in control cells 
and non-stimulatory when RNase T2 or TLR8 was absent (Figure 6C, gray bars). However, 
in vitro RNase-T2-digested RNA40 was active in control cells and also stimulatory in 
RNASET2−/− cells. As expected, TLR8 dependency was maintained for these in vitro-digested 
RNAs (Figure 6C, green bars). Hence, the ex cellulo RNA40 digestion using RNase T2 could 
bypass the requirement of lysosomal RNase T2. Intriguingly, RNase-A-derived degradation 
products were unable to trigger TLR8 activation in RNASET2−/− cells (Figure 6C, magenta bars). 
Moreover, their activity in control cells was present only when undigested RNA40S was 
present, as was the case in the undercut preparation (Figure 6C, +). To study this approach 
with a defined motif, we designed an ON that contained only one UUGU motif in an otherwise 
inert sequence context: (AC)7UUGUCU. As expected, digestion of this ON by RNase T2 
generated a major 17-mer fragment (Figure 6D), and stimulation experiments showed that 
this ON exerted RNase-T2-dependent TLR8 agonism (Figure 6E). Analogous to the results 
obtained with RNA40, ex cellulo digestion of this ON bypassed the requirement for 
endogenous RNase T2 (Figure 6E, green bars). We next wanted to test whether ONs directly 
terminating with the UUG motif would exert TLR8 agonism on their own. In order to be able 
to employ high-performance liquid chromatography (HPLC) to purify these ONs, we 
exchanged the inert AC portion of (AC)7UUGUCU into a non-phosphorothioate 
deoxynucleotide (dAdC)7 (Figure 6F). Similarly to the previous results, this ON exerted RNase-
T2-dependent TLR8 agonism, and ex cellulo digestion bypassed RNase T2 requirement (Figures 
S6A and S6B). We next compared a version of this ON terminating with UUG with a variant 
lacking the 3′ terminal guanosine (UU). These experiments showed that UUG could exert TLR8 
agonism, whereas the UU variant was completely inactive (Figure 6G, insert). However, this 
activity was greatly reduced in comparison with that of the ex-cellulo-digested RNase T2 
substrate UUGUCU (Figure 6G and Figures S6C and S6D) and also partially RNase T2 
dependent. We considered that two possible scenarios might be accountable for this 
difference. On the one hand, the ex-cellulo-digested ON additionally contained the 3′-terminal 
UCU fragment, which could serve the function of supplying lysosomal uridine, the abundance 
of which would be dependent on RNase T2 and exogenous RNA delivery (Figures 4 and 5). On 
the other hand, the 2′,3′-cyclophosphate group of the RNase-T2-digested fragment could be 
responsible for its higher potency over the here-tested 3′hydroxyl-terminated fragment. To 
address these scenarios, we obtained highly pure 3′ OH, 3′ phosphate, or 2′,3′-
cyclophosphate-terminated (dAdC)8UUG by HPLC purification and tested these fragments in 
the absence or presence of a “uridine donor” (Figure 6H and Figure S6E). To this end, we co-
delivered the previously characterized UUAA ON, which did not exert TLR8 activity but 
resulted in the release of U>p to the same extent as TLR8-agonistc ONs. These experiments 
revealed that the three (dAdC)8UUG ONs exerted 10%–20% of the activity of the ex-cellulo-
digested substrate on their own (Figure 6H, left). However, co-delivery of UUAA greatly 
enhanced the activity of the three UUG ONs, now paralleling the activity of the ex-cellulo-
digested substrate (Figure 6H, right). The UUAA ON itself exerted no activity at all. Comparing 
the ONs with the three different UUG 3′ termini revealed that the 2′,3′-cyclophosphate moiety 
increased activity by approximately 2-fold. In summary, these results indicate that the RNase 
T2 requirement for TLR8 stimulation can be bypassed by the delivery of guanosine-terminated 
ON fragments through the direct engagement of the second binding pocket of TLR8. Under 
these conditions, sufficient uridine levels are required so that the engagement of the second 
binding pocket can trigger TLR8 activation. 
  
 
Figure 6: RNase T2 Degradation Products Bypass the Lack of RNase T2 to Exert TLR8 Agonism. (A) RNA40 was 
digested with either RNase T2 or RNase A, and BLaER1 cells were transfected with thus-obtained degradation 
products. (B) Urea gel of RNA40S digested with RNase T2 or different concentrations of RNase A. (C) Digested 
RNA40S from (B) or respective controls were used to stimulate BLaER1 cells. (D) Urea gel of full-length and RNase-
T2-digested (AC)7-UUGUCU. (E) BLaER1 cells were stimulated with either digested or undigested (AC)7-UUGUCU 
and the indicated controls. (F) List of ONs used for the stimulations in (G) (top) and (H) (bottom). Arrow indicates 
in vitro digestion with RNase T2. (G) ONs depicted in (F) were used to stimulate BLaER1 cells. Control stimuli are 
shown in Figure S6D. (H) The ONs depicted in (F) were purified by HPLC and then used to stimulate BLaER1 cells. 
To obtain the (dAdC)7UUG>p cyclophosphate, we digested (dAdC)7-UUGUCU ON by RNase T2 and purified by 
HPLC. Control stimuli are shown in Figure S6F. In the right panel, all ONs were co-transfected with the DNA-RNA 
hybrid (dN)6UUAA(dN)8 (1.2 μg), serving as an uridine donor. IL-6 was measured after 14 h. Data are depicted as 
mean + SEM of three independent experiments or one of three representative gels. Statistics indicate 
significance by two-way ANOVA: ∗∗∗∗p ≤ 0.0001; ∗∗∗p ≤ 0.001; ∗∗p ≤ 0.01; ∗p ≤ 0.05; ns, not significant. See also 
Figure S6. 
Staphylococcus aureus Detection in Myeloid Cells Depends on RNase T2 Upstream of TLR8 
To explore whether RNase T2 also plays a role in the recognition of a microbial pathogen that 
is sensed by TLR8, we studied the recognition of Staphylococcus aureus. Previous work has 
established that human myeloid cells largely employ TLR8 to detect S. aureus (Bergstrøm 
et al., 2015, Krüger et al., 2015). BLaER1 monocytes responded to purified Staphylococcal RNA 
delivered by pR in an RNase-T2- and TLR8-dependent fashion (Figures 7A–7C). Next, we 
incubated BLaER1 monocytes with live S. aureus at different MOIs (Figure 7D). Under these 
conditions, BLaER1 cells displayed a potent IL-6 response upon stimulation with S. aureus, and 
this response was again largely dependent on RNase T2 and TLR8 (Figure 7E). Furthermore, to 
address whether RNA from live S. aureus is degraded by RNase T2 in cellulo, we metabolically 
labeled S. aureus by using stable-isotope-containing medium (15N) and analyzed isotope-
labeled metabolites in BLaER1 monocytes upon infection (Figure 7F). Doing so, we could 
detect S. aureus-derived ribonucleosides in infected cells, yet these metabolites were not 
affected by RNase T2 deficiency (Figure 7G and Figures S7A and S7B). At the same time, 
S. aureus-dependent G>p and A>p could be detected in control cells but not in RNASET2−/− 
cells (U>p and C>p levels could not be determined). Altogether, these results suggest that the 
recognition of a complex bacterial RNA molecule, such as the one encountered in the context 
of S. aureus infection, depends on RNase T2 upstream of TLR8. 
 
Figure 7: S. aureus Detection in Myeloid Cells Depends on RNase T2 Upstream of TLR8. (A) RNA was isolated 
from S. aureus to stimulate BLaER1 cells. (B) Bioanalyzer spectrum of undigested or RNase-T2-digested S. aureus 
RNA. (C) BLaER1 cells stimulated with S. aureus RNA and indicated controls. (D) Schematic view of how live 
S. aureus was used to stimulate BLaER1 cells at different MOIs. (E) After infection or stimulation with indicated 
controls, IL-6 was measured. (F) Schematic view of how S. aureus was grown in 15N-labeled medium and used to 
stimulate BLaER1 cells. (G) S. aureus-derived metabolites were analyzed by LC-MS after infection. Data are 
normalized to control cells (note logarithmic scale). Data are depicted as mean + SEM of two (G), three (E), or 
four (C) independent experiments. Statistics indicate significance by two-way ANOVA: ∗∗∗∗p ≤ 0.0001; ∗∗∗p ≤ 0.001; 
∗∗p ≤ 0.01; ∗p ≤ 0.05; ns, not significant; n.d., not detected. See also Figure S7. 
Discussion 
Despite its central function in antimicrobial immunity and autoimmunity, our mechanistic 
understanding of the RNA-sensing PRR TLR8 has remained limited. Here, we identified the 
lysosomal endoribonuclease RNase T2 as a pivotal upstream component for the recognition 
of RNA molecules by TLR8. Using various model substrates, we found that human RNase T2 
cleaves ssRNA molecules at RU, generating adenosine- or guanosine-2′,3′-cyclophosphate-
terminated fragments. In line with previous structural studies, such oligoribonucleotides 
constitute ideal ligands for engaging the second binding pocket of TLR8. However, because of 
its substrate specificity, RNase T2 also serves to increase catabolic uridine, which engages the 
first binding pocket of TLR8, another prerequisite for the activation of this PRR. However, this 
functionality of releasing uridine from exogenous substrate RNA is not sufficient to activate 
TLR8, and uridine release can also be uncoupled from RNase T2. Interestingly, RNase T2 
functions in a largely non-redundant fashion upstream of TLR8. This implies that other 
lysosomal RNases, of which there are several within the lysosome, cannot produce the 
3′ termini required for engaging TLR8. In line with this notion, endoribonucleases that are part 
of the RNase A family cleave 3′ of pyrimidines, hence generating incompatible 3′ ends for the 
second binding pocket of TLR8. As such, it appears that hTLR8 has evolved to specifically sense 
the presence of RNase T2 degradation products within the lysosome. 
RNase T2 is part of an endoribonuclease family that consists of RNase A, RNase T1, and RNase 
T2. Members of these transferase-type endoribonucleases cleave their substrate via a 2′,3′-
cyclophosphate intermediate to a 3′-phosphate (MacIntosh, 2011). Apart from their shared 
mode of action, all of these RNases locate to compartments of the secretory pathway, as such 
ending up in the lysosome or the extracellular space. Whereas RNase T1 family members are 
found only in fungi and bacteria, RNase A members exist only in the vertebrate system. Unlike 
RNase A members, RNase T2 family members are found across all living organisms, excluding 
the domain Archaea. Indeed, RNase T2 is highly conserved in metazoan, and unlike RNase A 
family members, of which there are 13 encoded in the human genome, it has not undergone 
extensive duplication or diversification events. This would argue for an important 
housekeeping function of RNase T2. One possibility is that RNase T2 plays an important role 
in ribosome turnover, e.g., in the context of ribophagy. In line with this notion, zebrafish 
deficient in RNase T2 activity display a marked accumulation of rRNA within lysosomes, 
although this is mostly confined to the central nervous system (Haud et al., 2011). 
Structural studies of RNase T2 have revealed two distinct base-coordinating sites (B1 and B2 
sites) located 5′ and 3′ to the scissile bond (MacIntosh, 2011). Both sites can affect substrate 
specificity of RNase T2. For example, the B2 site of the bitter gourd RNase T2 ortholog MC1 
accommodates uridine and thus dictates its substrate specificity for 5′-NU-3′ dinucleotides 
(Suzuki et al., 2000) (Numata et al., 2003). Human RNase T2 is structurally highly related to 
MC1, and the base-coordinating amino acid residues in its B2 site are orthologous to the ones 
of MC1 (Thorn et al., 2012). In line with this notion, all of the here-identified in vitro digestion 
RNA fragments displayed termini that were the result of a cleavage event upstream of uridine. 
In addition, we found the B1 site to be specific to purine nucleotides (R), rendering the 
substrate specificity of RNase T2 to be RU. To further assess the activity and substrate 
specificity of RNase T2 and RNase A family enzymes in cellulo, we made use of the possibility 
to measure 2′,3′-cyclophosphate-terminated nucleotides of both exogenous and endogenous 
origins. Indeed, with currently little known about the fate of lysosomal RNA degradation 
products, we would consider the analysis of these immediate endonuclease products as an 
ideal proxy of the catabolic activity of these enzymes. These analyses revealed that RNASET2−/− 
cells displayed a marked drop in G>p and A>p and G>p- and A>p-terminated nucleotides of 
both endogenous and exogenous sources. Given that RNase A family enzymes mainly cleave 
after pyrimidines, one would expect C>p and U>p levels to be unaffected in the absence of 
RNase T2. Indeed, C>p levels were largely intact in the absence of RNase T2 yet were affected 
by deletion of one of the RNase A family enzymes (RNASE1). However, U>p levels were almost 
decreased as much as the levels of G>p or A>p. Because RNase T2 cleaves upstream of uridine, 
RNase T2 deficiency is expected to decrease U>p levels by theoretically 50%. Why U>p levels 
were affected beyond these concentrations is unclear. It is conceivable that RNase T2 also 
accepts uridine in its B1 site but with lower affinity, thereby masking this activity in our 
undercutting conditions. At the same time, it is possible that additional factors beyond the 
dinucleotide substrate specificity of RNase T2 affect its activity in cellulo. Nevertheless, apart 
from its impact on the abundance of purine-terminated RNA fragments and nucleotides, we 
can infer from these results that the lysosomal concentration of uridine is markedly decreased 
in the absence of RNase T2. 
By uncovering the role of RNase T2 and its unique substrate specificity upstream of TLR8, our 
studies shed light on the nature of the MAMP and/or DAMP (damage-associated molecular 
pattern) that is sensed by TLR8. In fact, RNase T2 affects the availability of ligands for both 
binding pockets of TLR8. Although these functionalities are interconnected in the context of a 
physiological RNA ligand being sensed, it is important to consider these steps separately 
because they differ in quality and relevance. 
The second binding pocket of TLR8 has been shown to accommodate guanosine-terminated 
di- and trinucleotides, whereas the nucleotide(s) preceding guanosine have been found to be 
pyrimidine, preferably uridine (Tanji et al., 2015). With its unique substrate specificity for RU 
within ssRNA, RNase T2 generates purine-terminated ribonucleotides that can engage this 
second binding pocket of TLR8. Indeed, across different stimulatory conditions tested, RNA-
derived (U)UR>p fragments were RNase T2 dependent and closely correlated with TLR8 
agonistic activity. In fact, our studies suggest that RNase T2 is the only lysosomal 
endoribonuclease that generates aforementioned 3′ termini, thus explaining its non-
redundant function in RNA recognition upstream of TLR8. As an additional feature of 
endoribonuclease cleavage, the thus-generated 3′ termini harbor a 2′,3′-cylcophosphate 
configuration. Although this feature is neither sufficient nor required for TLR8 agonistic 
activity, it shows enhanced activity compared with that of 3′-OH or 3′-phosphate-terminated 
fragments. 
The first binding pocket of TLR8 binds uridine. With its strict specificity for uridine in the B2 
position, RNase T2 also critically contributes to catabolism-associated uridine levels and thus 
the activation of TLR8. To this end, lack of RNase T2 resulted in approximately 4-fold reduced 
U>p levels under steady-state conditions, and after stimulation an approximately 15-fold 
difference was observed. In that regard, upon delivery of a sole second binding pocket agonist 
(UUG), the TLR8 response of control and RNase-T2-deficient cells was much reduced in 
comparison with that of cells that were stimulated with an ex-cellulo-digested ON 
(UUG↓UCU). However, this could be reverted by co-delivery of a non-stimulatory ON (UUAA) 
to increase uridine levels to concentrations that paralleled the uridine concentrations of TLR8-
agonistic ONs. Under these conditions, the stimulatory capacity of the UUG-terminated ONs 
was strongly increased to the level of the ex cellulo RNase-T2-digested precursor. From these 
experiments we can conclude that uridine released from exogenous RNA sources strongly 
contributes to TLR8 activation under these conditions. Nevertheless, it is important to note 
that despite its critical role in TLR8 activation, catabolic uridine is not sufficient in the context 
of a complex RNA molecule’s being sensed, and RNase T2 is not its sole source. As such, the 
stimulatory activity of an ON did not correlate with the abundance of ON-derived uridine 
levels, and an increase in uridine levels could be achieved in the absence of RNase T2. 
In summary, RNase T2 activity is required for the TLR8-dependent recognition of complex RNA 
molecules by carrying out two independent functions that are both dictated by its substrate 
specificity. On the one hand, by regulating catabolism-derived uridine levels, RNase T2 
critically contributes to the engagement of the first binding pocket. On the other hand, RNase 
T2 non-redundantly generates agonistic ligands for the second binding pocket of TLR8, which 
allosterically controls the affinity for uridine of the first binding pocket. Of note, this regulatory 
step is critically required in the context of a natural RNA substrate being sensed. 
Loss-of-function mutations within the human RNASET2 gene result in a cystic 
leukoencephalopathy, which resembles congenital cytomegalovirus infection in clinical and 
neuroradiological features (Henneke et al., 2009). It is tempting to speculate that this 
RNASET2-related leukodystrophy shares the same pathomechanism with Aicardi-Goutières 
syndrome (AGS) (Rice et al., 2017). In AGS, defects in nucleic acid metabolism result in the 
inadvertent engagement of nucleic-acid-sensing PRRs and thus the initiation of 
autoinflammation (Crow and Manel, 2015). At first sight, this association seems 
counterintuitive given that our data imply a pro-inflammatory role of RNase T2 upstream of 
TLR8. However, the fact that different RNA-sensing PRRs harbor different ligand specificities 
could explain this scenario. It is conceivable that RNase T2 deficiency results in the 
accumulation of undigested RNA in the lysosome and leads to its cytosolic translocation and 
engagement of cytosolic RNA sensors. Interestingly, a similar scenario has been described for 
the lysosomal endonuclease DNase II. On the one hand, DNase II activity is required for 
degrading complex DNA molecules within the lysosome into fragments so that TLR9 can be 
engaged (Chan et al., 2015). On the other hand, lack of DNase II results in the accumulation of 
lysosomal DNA, which subsequently leads to its translocation and activation of the cGAS-
STING pathway (Ahn et al., 2012, Gao et al., 2015). As such, RNase T2 activity could require a 
tight balance between its pro-immunogenic role upstream of TLR8 and its potentially anti-
inflammatory role as an RNA-degrading enzyme. In that respect, the activity of these 
lysosomal nucleases appears to be well protected against potential pathogen-encoded, 
counter regulatory mechanisms in that perturbation of their activities would result in the 
initiation of antimicrobial defense mechanisms. 
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Supporting Figure 1: Characterization of TLR7 and TLR8 in BLaER1 Monocytes, Related to Figure 1. (A) Volcano 
plot showing gene expression differences of differentiated versus un-differentiated BLaER1 cells. The negative 
log10 pvalues (y axis) are plotted against the log10 fold changes in gene expression (x axis). Significantly (adjusted 
p-value <0.05 and absolute fold change >2) upregulated genes are highlighted in red, downregulated genes are 
highlighted in blue. TLR4, 7 and 8 are specifically highlighted. (B) BLaER1 Ctrl. and TLR8−/− cells were stimulated 
using Lipofectamine 2000 with and without RNA40S. (C) BLaER1 cells were stimulated with different amounts of 
RNA40°. The unstimulated control shown in (B) and (C) is the same as in Figure 1D, as it is derived from the same 
experiment. (D) Different RNAs were tested for TLR8 activation. P20 is a self-complementary RNA forming 
hairpins, whereas P20-5M is only a partially self-complementary RNA. Data are depicted as mean + SEM of three 
(B and C) or four (D) independent experiments. Statistics indicates significance by two-way ANOVA: ∗∗∗p ≤ 0.001, 
∗∗p ≤ 0.01, ∗p ≤ 0.05, ns = not significant. 
 
Supporting Figure 2: RNASE1−/−, RNASE2−/−, and RNASE6−/− Cells Show No Reduced Response to RNA40 
Stimulation, Related to Figure 2. (A–C) BLaER1 control, RNASE1, RNASE2 and RNASE6-deficient cells were 
stimulated with RNA40S, TL8-506, R848 and LPS. Controls are identical for RNASE1−/− and RNASE6−/− cells as they 
derive from the same experiment. (D) THP-1 wild type, RNASET2−/− and TLR8−/− cells were stimulated as indicated. 
(E) BLaER1 control and RNASET2−/− cells were stimulated as indicated. Data of Ctrl. cells are identical to the ones 
in Figure S1D as they derive from the same experiment. Data are depicted as mean + SEM of three (A–D) or four 
(E) independent experiments. Statistics indicates significance by two-way ANOVA: ∗∗∗∗p ≤ 0.0001; ∗∗∗p ≤ 0.001, 
∗∗p ≤ 0.01, ∗p ≤ 0.05, ns = not significant. 
 
Supporting Figure 3: Identifying Possible RNase T2 Degradation Products by In Vitro Digestion of RNA40, 
Related to Figure 3. (A) List of all possible fragments associated with the in vitro digest of RNA40S with RNase T2, 
analyzed by HPLC/MALDI-TOF. All found and calculated ([M-H]-) masses are shown. The color code refers to the 
probability that fragments could be assigned to the one depicted. (B) Most likely hits of RNA40S digested with 
RNase T2 based on the analysis from (A). (C) Assuming RNase T2 is only capable of cleaving RNA40 between G 
and U residues, all possible fragments are depicted. The ticks indicate which of these fragments could be 
confirmed by HPLC/MALDI-TOF. (D) Urea gel of in vitro digested RNA P20 and P20-5M with RNase T2. P20 is a 
self-complementary RNA fragment and forms hairpins, whereas P20-5M is only partially self-complementary 
RNA. One representative gel of two independent experiments is shown. 
 
Supporting Figure 4: Cells Deficient in RNase A Family Enzymes Show Different RNA40 Catabolism in 
Comparison with RNASET2−/− Cells, Related to Figure 4. (A) Whole cell lysate of unstimulated BLaER1 cells with 
indicated genotypes were analyzed by LC-MS. Data are normalized to Ctrl. cells (note logarithmic scale). (B–D) 
Whole cell lysate of control, RNASE1−/−, RNASE2−/− and RNASE6−/− BLaER1 cells stimulated with RNA40S was 
analyzed by LC/MS (14 h after stimulation). RNA40S derived metabolites are shown. Data are normalized to Ctrl. 
cells (note logarithmic scale). Data are depicted as mean + SEM of three independent experiments. Statistics 
indicates significance by a Welch’s unequal variances t test. ∗∗∗p ≤ 0.001, ∗∗p ≤ 0.01, ∗p ≤ 0.05; ns, not significant; 
n.d., not detected. 
 
Supporting Figure 5: Crystal Structure of the Second Pocket of TLR8, Related to Figure 5. Crystal structure of the 
second pocket of TLR8 bound to UG (PDB, 4R07). Yellow dashed lines indicate hydrogen bonds whereas green 
dashed lines show π- π-interactions. The atoms are color coded as follows: nitrogen, blue; oxygen, red; phosphor, 
orange; carbon, light blue and gray. 
 
Supporting Figure 6: RNase T2 Degradation Products Bypass the Lack of RNase T2, Related to Figure 6. (A) Urea 
gel of full-length and RNase T2 digested (dAdC)7UUGUCU. (B) BLaER1 cells of indicated genotypes were 
stimulated with either digested or undigested (dAdC)7-UUGUCU (0.9 μg/condition) and the indicated controls. 
(C) Urea gel of the following full-length ONs: (dAdC)7-UUGUCU, (dAdC)7-UUG, (dAdC)7-UU and (dAdC)8.(D) 
Control stimulation of BLaER1 cells associated with (Figure 6G). (E) Control stimulation of BLaER1cells associated 
with (Figure 6H). Data are depicted as mean + SEM of three independent experiments or one of two 
representative gels is shown. Statistics indicates significance by two-way ANOVA. ∗∗∗∗p ≤ 0.0001; ∗∗∗p ≤ 0.001, ∗∗p 
≤ 0.01, ∗p ≤ 0.05, ns = not significant. 
 
Supporting Figure 7: Figure S7. 15N-Labeled S. aureus Detection in Myeloid Cells Depends on RNase 
T2 Upstream of TLR8, Related to Figure 7. (A) Schematic overview of experimental setup. S. aureus was grown 
in 15N-labeled medium, harvested and used to stimulate differentiated BLaER1 cells. 1 h after infection 
gentamicin was added and another 14 h later IL-6 release was measured by ELISA. (B) Stimulation of BLaER1 cells 
with different MOI of 15N-labeled S. aureus. Data are depicted as mean + SEM of three independent experiments. 





Key Resources Table 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Direct-Blot HRP anti-FLAG tag BioLegend 
Cat#637311; RRID: 
AB_2566706 
Anti-RNase T2 Sigma-Aldrich 
Cat#HPA029013; 
RRID: AB_10602922 











S. aureus subsp. aureus ATCC ATCC 6538 
Chemicals 
Agilent RNA 6000 Nano Kit Agilent Cat#5067-1511 
Ammonium persulfate Sigma-Aldrich Cat#A3678 
Blood agar plate OXOID Cat#PB5039A 
Doxycycline hyclate Sigma-Aldrich Cat#D9891 
EDTA (0.5M) Thermo Fisher Cat#15575020 





Gentamicin Thermo Fisher Cat#15750060 
HisTrap™ GE Healthcare Cat#17-5247-01 
ISOGRO®-15N Powder-Growth Medium Sigma-Aldrich Cat#606871 




LPS-EB Ultrapure InvivoGen Cat#tlrl-3pelps 
Nitrocellulose membrane (0.45μm) GE Healthcare Cat#10600002 
REAGENT or RESOURCE SOURCE IDENTIFIER 





Phenol/Chloroform/Isoamylalkohol Roth Cat#A156.3 





poly-L-arginine Sigma-Aldrich Cat#P7762 





Recombinant Human IFN-γ PeproTech Cat#300-02 


















Superdex-200 16/600 GE Healthcare Cat#28989335 




TL8-506 InvivoGen Cat# tlrl-tl8506 
TEMED Roth Cat#2367.3 




β-Estradiol Sigma-Aldrich Cat#E8875-250MG 
Critical Commercial Assays 
Human IL-6 ELISA Set BD Biosciences Cat#555220 
REAGENT or RESOURCE SOURCE IDENTIFIER 
MiSeq Reagent Kit v2, 300 Cycles Illumina Cat#MS-102-2002 
Deposited Data 
BLaER1 RNA Seq data This paper GEO: GSE138913 
Experimental Models: Cell Lines 
BLaER1 human b-cell to monocyte trans-differentiation cell line 




Gaidt et al., 
2017 
N/A 





RNA40 (rGrCrCrCrGrUrCrUrGrUrUrGrUrGrUrGrArCrUrC) IDT N/A 
P20 (rUrUrGrArArGrGrArCrArUrGrUrCrCrUrUrCrArA) IDT N/A 
P20-5M (rUrGrUrCrCrUrGrArCrArUrGrUrCrCrUrUrCrArA) IDT N/A 
dN∗dN∗dN∗dN∗dN∗dN∗U∗U∗G∗U∗dN∗dN∗dN∗dN∗dN∗dN∗dN∗dN IDT N/A 
dN∗dN∗dN∗dN∗dN∗dN∗U∗U∗G∗A∗dN∗dN∗dN∗dN∗dN∗dN∗dN∗dN IDT N/A 
dN∗dN∗dN∗dN∗dN∗dN∗U∗U∗G∗G∗dN∗dN∗dN∗dN∗dN∗dN∗dN∗dN IDT N/A 
dN∗dN∗dN∗dN∗dN∗dN∗U∗U∗G∗C∗dN∗dN∗dN∗dN∗dN∗dN∗dN∗dN IDT N/A 
dN∗dN∗dN∗dN∗dN∗dN∗U∗U∗G∗dN∗dN∗dN∗dN∗dN∗dN∗dN∗dN∗dN IDT N/A 
dN∗dN∗dN∗dN∗dN∗dN∗U∗U∗A∗U∗dN∗dN∗dN∗dN∗dN∗dN∗dN∗dN IDT N/A 
dN∗dN∗dN∗dN∗dN∗dN∗U∗U∗A∗A∗dN∗dN∗dN∗dN∗dN∗dN∗dN∗dN IDT N/A 
rArArArArGrGrArA IDT N/A 
rArArArArGrArArA IDT N/A 
rArArArArGrUrArA IDT N/A 
rArArArArGrCrArA IDT N/A 
rArArArArArGrArA IDT N/A 
rArArArArArArArA IDT N/A 
REAGENT or RESOURCE SOURCE IDENTIFIER 
rArArArArArUrArA IDT N/A 
rArArArArArCrArA IDT N/A 
rArArArArUrGrArA IDT N/A 
rArArArArUrArArA IDT N/A 
rArArArArUrUrArA IDT N/A 
rArArArArUrCrArA IDT N/A 
rArArArArCrGrArA IDT N/A 
rArArArArCrArArA IDT N/A 
rArArArArCrUrArA IDT N/A 
rArArArArCrCrArA IDT N/A 
rA∗rC∗rA∗rC∗rA∗rC∗rA∗rC∗rA∗rC∗rA∗rC∗rA∗rC∗rU∗rU∗rG∗rU∗rC∗rU IDT N/A 
dAdCdAdCdAdCdAdCdAdCdAdCdAdCdAdC IDT N/A 
dAdCdAdCdAdCdAdCdAdCdAdCdAdC∗rU∗rU∗rG∗rU∗rC∗rU IDT N/A 
dAdCdAdCdAdCdAdCdAdCdAdCdAdC∗rU∗rU∗rG IDT N/A 
dAdCdAdCdAdCdAdCdAdCdAdCdAdC∗rU∗rU∗rG-3′-phosphate IDT N/A 
dAdCdAdCdAdCdAdCdAdCdAdCdAdC∗rU∗rU IDT N/A 
Recombinant DNA 
pcDNA3.1_RNase T2_PreScission_6xHis This study N/A 
pLI_hu_RNase T2_FLAG_Puro This study N/A 
pLI_mScarlet _Puro This study N/A 
CMV-mCherry-Cas9 
Schmid-Burgk 




et al., 2014 
N/A 
pCAS9-mCherry-gRNA 
Schmidt et al., 
2015 
N/A 
Software and Algorithms 
GraphPad Prism 8 GraphPad N/A 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Outknocker 
Schmid-Burgk 
et al., 2014 
N/A 
Lead Contact and Materials Availability 
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Veit Hornung (hornung@genzentrum.lmu.de). 
Experimental Model and Subject Details 
Cell culture 
BLaER1 cells and THP-1 were cultured in RPMI medium 1640, supplemented with 10% (v/v) 
FCS, L-glutamine and 100 U/mL Penicillin-Streptomycin. HEK293T cells were cultured in 
DMEM (same supplements as RPMI). BLaER1 cells were trans-differentiated for 5-6 day in 
medium containing 10 ng/mL IL-3, CSF1 (MPI of Biochemistry, Munich) and 100 nM β-
estradiol. BLaER1 cells with a CASP4−/− genetic background were used as control cells (Ctrl.) 
throughout the whole study. In the course of these studies, we serendipitously identified that 
BLaER1 cells express transcripts of SMRV (Squirrel monkey retrovirus) and subsequent 
experiments confirmed that BLaER1 cells harbor the SMRV proviral genome. Testing early 
passages of BLaER1 cells by Dr. Thomas Graf (Thomas.Graf@crg.eu) confirmed that the 
parental BLaER1 cell line (Rapino et al., 2013) is positive for SMRV. Of note, extensive 
characterization of BLaER1 monocytes in comparison to other human myeloid cells has not 
provided any indication that SMRV positivity would impact on the functionality of these cells 
as myeloid cells. 
Method Details 
Bioanalyzer 
S. aureus total RNA analysis was performed using the Agilent Bioanalyzer device. The RNA 
6000 Nano kit (#5067-1511) was used according to the supplier’s protocol. 
Cell stimulation 
BLaER1 cells were stimulated 5-6 days after trans-differentiation with ORN RNA40, which has 
a phosphorothioate backbone (RNA40S), or with the un-stabilized RNA40 (RNA40°). If not 
otherwise indicated, RNA40 was complexed in a 1:1 ratio with poly-L-arginine (0.6 μg per 
condition). For conditions involving ex cellulo digests (Figure 6), 1.2 μg per condition were 
used for all ONs to account for the cleavage activity of RNase T2. RNA and poly-L-arginine were 
separately incubated for 5 min at RT with Opti-MEM (GIBCO®) (25 μl per 96-well each). 
Afterward the two reagents were mixed and incubated another 20 min at RT. The medium 
was changed with 100 μl RPMI per 96-well prior to adding 50 μl transfection mix. The 
transfection of RNA40 with Lipofectamine 2000 (LF) was performed according to the supplier’s 
protocol. Furthermore, cells were stimulated with either 200 ng/mL LPS, 1 μg/mL R848 or 
100 ng/mL TL8-506. To stimulate cells with degradation products, ONs were digested with 
either RNase T2 (self-purified) or bovine pancreatic RNase A (Invitrogen, Maxiprep Kit, 
K210017). The RNA was mixed with IDTE buffer pH 8 in a 1:1 ratio and after adding the enzyme 
incubated for 20 min at 37°C. The digested RNA was transfected according to the protocol 
above. All stimulations were carried out for 14-16 h at 37°C. 
For infections with S. aureus subsp. aureus (ATCC® 6538) bacteria were grown overnight on a 
blood agar plate at 37°C. The next day bacteria were resuspended in PBS, centrifuged 5 min 
at 4000 g and resuspended in RPMI medium (without antibiotics). Cells were stimulated with 
100 μl per 96-well at the indicated MOI for 1 h at 37°C. Afterward the medium was topped up 
with 50 μl fresh RPMI medium containing gentamicin, leading to a final concentration of 
50 μg/mL. Cells were incubated for another 14 h at 37°C. Stimulation with 15N labeled S.aureus 
was performed the same way as with unlabeled bacteria. 
THP-1 cells were differentiated with 100 ng/mL PMA for 16 h. Afterward cells were washed 
twice with PBS and seeded into new dishes. THP-1 cells were stimulated after a resting phase 
of 3 days and a 6 h incubation with IFN-γ. For stimulation, RNA40 (1200 ng/ 96-well) was 
complexed in a 1:1 ratio with poly-L-arginine. Therefore, the RNA and poly-L-arginine were 
separately incubated for 5 min at RT with Opti-MEM (GIBCO®) (25 μl per 96-well each). 
Afterward the two reagents were mixed and incubated another 20 min at RT. The medium 
was changed with 100 μl RPMI per 96-well prior to adding 50 μl transfection mix. As control, 
THP-1 cells were stimulated with either 0.33 μg/mL Pam3CSK4, 2 μg/mL R848 or 200 ng/mL 
TL8-506. All stimulations were carried out for 14-16 h at 37°C. 
CRISPR/Cas9 mediated knockout-cell line generation 
Gene deficient BLaER1 cells were generated using a CRISPR/Cas9 based knockout workflow as 
previously described (Schmid-Burgk et al., 2014). Briefly, sgRNAs (18 or 20-mer) targeting an 
early coding exon were designed for each gene. BLaER1 cells were electroporated with one 
plasmid expressing sgRNA and one expressing mCherry-Cas9 (pLK0.1-gRNA-CMV-GFP, CMV-
mCherry-Cas9), using a Biorad GenePulser device. mCherry positive cells were sorted and 
cloned by limiting dilution. After identifying monoclones, cells were replated and grown to 
genotype them using deep sequencing (Illumina’s Miseq-platform). For every knockout 
several clones containing all-allelic frameshift mutations were picked and used for 
experiments. 
Immunoblotting 
Immunoblotting of whole cell lysate was performed as follows: Cells were detached from the 
dish using PBS-EDTA (diluted 1:250 in PBS), pooled and centrifuged 5 min at 500 g. The pellet 
was lysed in DISC buffer and again centrifuged 10 min at 16.000 g to get rid of the nuclei. The 
supernatant was mixed with 6x Lämmli buffer and denatured for 5 min at 85°C. After 
separation by tris-glycine denaturing SDS-PAGE, proteins were blotted onto 0.45 mm 
nitrocellulose membranes, blocked in 5% milk and incubated with indicated primary and 
corresponding secondary antibodies. Chemiluminescent signals were recorded with a CCD-
camera and respective images contrast-enhanced in a linear fashion. 
Kits 
hIL-6 ELISA were performed according to the supplier’s protocol. 
Lentiviral expression 
RNase T2 was amplified from cDNA derived of BLaER1 cell lysate and cloned into a doxycycline 
inducible (dox-on) plasmid using conventional restriction enzyme cloning (pLIX_RNase 
T2_3xFLAG_Puro). As control a pLIX_mScarlet_Puro plasmid was used. BLaER1 cells of 
indicated genotype were transduced and selected by using puromycin. The polyclonal cell 
population was then used for further experiments. 
LC/MS 
3x106 BLaER1 cells were lysed for 10 min on ice in 750 μl of a 1:1 mixture of water and 
acetonitrile. Cells were spun down at 21.000 g for 10 min and the supernatant was flash 
frozen. The samples were freeze-dried overnight and the fluffy white content was re-dissolved 
in 300 μL of milliQ-water. Each sample was centrifuged at 21.000 g and 4°C for 30 min, and 
the supernatant was transferred to a new tube. Prior to MS-measurement, 10 μL of a 0.3 μM 
solution of 2-(D3-methyl)guanosine in milliQ-water (D3-m2G); synthesized in the Carell group 
(Globisch et al., 2011) was added as internal standard to 90 μL of the sample. The mixture was 
vortexed for 60 s. The LC-HESI-MS analysis of the samples, containing the soluble pool of the 
cells and 3 pmol of D3-m2G as internal standard, was performed on a Dionex Ultimate 3000 
HPLC system coupled to a Thermo Fisher LTQ Orbitrap XL mass spectrometer. For 
comparability, the injection volume was always 90 μL (of 300 μL total sample volume) per 
technical replicate. Nucleosides / nucleotides were separated on an Interchim Uptisphere120-
3HDO C18 column whose temperature was maintained at 30°C. Elution buffers were buffer A 
(2 mM NH4HCOO in H2O; pH 5.5) and buffer B (2 mM NH4HCOO in H2O/MeCN 20/80 v/v; pH 
5.5) with a flow rate of 0.15 mL/min. The gradient was as follows: 0→10 min, 0% B; 
10→15 min, 0→0.1% B; 15→50 min, 0.1→5% B; 50→90 min, 5→100%. The chromatogram 
was recorded at 260 nm with a Dionex Ultimate 3000 Diode Array Detector, and the 
chromatographic eluent was directly injected into the ion source of the mass spectrometer 
without prior splitting. Ions were scanned in the positive polarity mode over a full-scan range 
of m/z 225-2000 with a resolution of 60,000. Parameters of the mass spectrometer were 
tuned with a freshly mixed solution of inosine (5 μM) in buffer A and set as follows: Capillary 
temperature 275.00°C; source voltage 4.80 kV; capillary voltage 0.00 V; tube lens voltage 
45.00 V. The ion chromatograms of the compounds of interest were extracted from the total 
ion current (TIC) chromatogram and the areas under the curves were integrated. The resulting 
integrals were divided by the corresponding integral obtained for the internal standard D3-
m2G improving the accuracy with respect to sample comparability. Of note, due to the fact 
that the introduction of the sulfur atoms created diastereomeric configurations of RNA40S-
derived fragments, several liquid chromatography peaks were detected for these molecules. 
For our analyses, we quantified the most abundant peak. 
In case of the cell extracts derived from S. aureus-infected cultures, fully 15N-labeled 
compounds were by far more abundant than the respective compounds lacking one or more 
of these heavy-atom labels. In these experiments, we therefore only considered the fully 
labeled compounds for MS-based quantification. 
For studying the substrate specificity of RNase T2, the same HPLC-ESI-MS-setup was used (a 
Dionex Ultimate 3000 HPLC system coupled to a Thermo Fisher LTQ Orbitrap XL mass 
spectrometer). While the elution buffers A (2 mM NH4HCOO in H2O; pH 5.5) and B (2 mM 
NH4HCOO in H2O/MeCN 20/80 v/v; pH 5.5) were the same as before, the flow rate 
(0.2 mL/min) and the gradient were optimized for these experiments. Here, the gradient was 
as follows: 0→5 min, 0% B; 5→20 min, 0→5% B; 20→30 min, 5→100% B. The chromatogram 
was again recorded at 260 nm with a Dionex Ultimate 3000 Diode Array Detector, and the UV 
trace was used to calculate the percentage of strand cleavage. To this end, the sum of the UV-
peak integrals of the cleavage products was divided by the sum of both the UV-peak integrals 
of the cleavage products and of the full strand. The MS-data generated in parallel was used to 
identify and verify the nature of all compounds. Please note that the oligomers were bearing 
multiple charges, so that the observed m/z-values were still within the MS full-scan range of 
m/z 225-2000. 
HPLC and MALDI 
1200 ng RNA was digested with RNase T2 (5-50 pg/μl) or RNase A (5-50 pg/μl) at 37°C for 
20 min. The reaction was performed in a total volume of 10 μl and filled up with water to 
300 μl after digesting. The sample was mixed with an equal volume of Roti®-
Phenol/Chloroform/Isoamylalcohol and flash frozen. The following steps were performed at 
room temperature. After thawing, the samples were centrifuged at 21.000 g for 3 min and the 
aqueous (upper) phase was transferred to a new tube. To remove traces of phenol, one 
volume-equivalent of chloroform was added to the aqueous phase and the mixture was 
vortexed for 30 s. After centrifugation at 21.000 g for 3 min, the aqueous (upper) phase was 
again transferred to a new tube. This chloroform extraction was repeated once and the 
remaining aqueous phase was subsequently freeze-dried overnight. The samples were re-
dissolved in 60 μL of milliQ-water and centrifuged at 21.000 g and 4°C for 30 min. Of the 
supernatant, 55 μL were transferred to a new vial and analyzed by HPLC with an injection 
volume of 50 μL. HPLC-analyses were performed on a Waters e2695 Separations Module. The 
ONs were separated on an EC 250/4 Nucleodur 100-3 C18ec column whose temperature was 
maintained at room temperature, and the chromatogram was recorded at 260 nm by a Waters 
2489 UV/Visible Detector. Elution buffers were buffer C (0.1 M NEt3/HOAc in H2O); and buffer 
D (0.1 M NEt3/HOAc in H2O/MeCN 20/80 v/v) with a flow rate of 0.5 mL/min. The gradient was 
as follows: 0→45 min, 0→25% D; 45→47 min, 25→100% D. The collected fractions were 
freeze-dried overnight, redissolved in 10 μL of milliQ-water, and desalted for 3 h using a MF-
Millipore Membrane Filter with 0.025 μm pore size. The subsequent MALDI-MS-analysis was 
performed on an autoflex II system from Bruker Daltonics in the negative polarity mode with 
1.5 μL of HPA-matrix (3-hydroxypicolinic acid) per 1.5 μL of the desalted sample. All MALDI 
experiments were repeated two times; oligomer masses were calculated as [M-H]− of the most 
abundant isotopologue. 
15N labeling of S. aureus 
To obtain S. aureus with 15N labeled RNA, ISOGRO-15N growth medium was used. It was 
dissolved in water to a final concertation of 0.5 g/ 50 mL and supplemented as follows: K2HPO4 
(10 mM), KH2PO4 (10 mM), MgSO4 (10 mM) and CaCl2 (0.1 mM). 5 mL of the growth medium 
were inoculated with S. aureus subsp. aureus (ATCC® 6538) and grown for 16 h. After 8 min 
centrifugation at 5000 g the bacteria were washed twice with PBS and used for stimulation. 
RNA precipitation 
Following HPLC purification, sodium acetate precipitation of the obtained RNA fragments or 
oligomers was performed. A 3 M sodium acetate solution was added to the RNA sample 
resulting in a final concertation of 0.3 M. 4 volumes of 100% ethanol were added, and the 
mixture was incubated for 1 h at −20°C. Afterward, the sample was centrifuged for 30 min at 
full speed and the pellet washed twice with 80% ethanol. After air drying the pellet, it was 
dissolved in RNase free water. 
Protein purification 
Human WT RNase T2 (encoding residues 1-256) was amplified from cDNA derived from 
BLaER1 cell lysate and cloned into either the piggyBac vector system Li et al. (2013) or a 
pcDNA3.1 vector using conventional restriction enzyme cloning. Both vectors were used to 
produce RNase T2 to over 90% purity determined by Coomassie stained protein gels and mass 
spectrometry. Activity was comparable between both sources. 
The pcDNA3.1_RNase T2_PreScission_6xHis plasmid was transfected into HEK293T cells. The 
supernatant of six 10 cm dishes were harvested and clarified (centrifugation at 500 g for 5 min, 
4°C). The supernatant was filtered and loaded onto a 1 mL HisTrap. The column was washed 
using 20 column volumes (CV) of wash buffer (20 mM K2HPO4, pH 7.5, 0.5 M NaCl, 20 mM 
Imidazole), the protein was eluted using a linear gradient of buffer A (wash buffer) and buffer 
B (1 M imidazole) over 10 CV. RNase T2 containing fractions were subjected to size exclusion 
chromatography (SEC) via a Superdex-200 16/600 in SEC buffer (200 mM NaAc pH 6.0, 50 mM 
NaCl). Fractions containing RNase T2 were pooled, concentrated and flash frozen for storage 
at −80°C. 
The piggyBac_RNase T2_PreScission_6xHis plasmid was used to generate stable HEK293T/17 
SF cells. Cells were grown to a density of 1 × 106 cells/mL in 1 L and treated with doxycycline 
(1 μg/mL). After 7 days, supernatant containing secreted RNase T2 was harvested. 1 L of 
harvested supernatant was concentrated using a Sartocon Slice 200, 10 kDa MW cutoff 
(Sartorius) in PBS. Concentrated protein was subjected to size exclusion chromatography in 
SEC buffer (200 mM NaAc, 50 mM NaCl, pH 6.0) using a HiLoad 26/60 Superdex 200 (GE 
healthcare). Fractions containing RNase T2 were concentrated using a 10 kDa cut-off, Amino 
Ultra 15 concentrator (Amicon), to a concentration of 11 mg/mL and flash frozen in liquid 
nitrogen. 
RNA-Seq 
Undifferentiated as well as differentiated BLaER1 cells were lysed in Trizol (2x106 / 1 ml) and 
total RNA was purified using the Zymo Direct-zol RNA Miniprep. Total RNA was used to 
generate stranded RNA sequencing libraries using the Encore Complete RNA-Seq library 
system of NuGEN. The libraries were sequenced on an Illumina HiSeq1500 device. The reads 
were aligned to the human reference genome (Ensemble genome version 91) using STAR 
(Dobin et al., 2013). The transcripts were quantified using RSEM (Li and Dewey, 2011) and 
TPM (Transcripts Per Kilobase Million) values are shown as gene expression. TPM values below 
2-6 or above 26 were trimmed to allow for data visualization (Figure 2A). All RNA-seq datasets 
were generated in this study, except the THP-1 one which is derived from a public database 
(GEO: GSE62171). 
Urea gel 
Urea gel was casted according to the supplier’s protocol using SequaGel Concentrate, 
SequaGel Diluent and SequaGel Buffer. The gel was run at 250 V for 70 min and stained using 
SYBR Gold. Afterward the gel was imaged. 
Quantification and Statistical Analysis 
If not otherwise indicated, statistical significance was determined by two-way ANOVA, and a 
post hoc test using Dunnett’s or Tukey’s correction for multiple testing. The exact number of 
replicates (n) is indicated within figure legends. All statistical analysis, except the analysis of 
the normalized LC/MS data, was performed using GraphPad Prism 8. ∗∗∗∗p ≤ 0.0001; ∗∗∗ p ≤ 
0.001, ∗∗ p ≤ 0.01, ∗ p ≤ 0.05, ns = not significant. If multiple comparisons are depicted with one 
comparison bar, the major tick of the comparison bar indicates the reference data to which 
the statements regarding the level of significance are made. LC/MS data was normalized by 
dividing the values of RNASET2−/− cells by the values of Ctrl. cells. These values were then 
transformed into a Log2 scale and a Welch’s unequal variances t test was performed. 
Undetectable values were replaced with 1/10 of the lowest non-zero value of the 
corresponding dataset. The analysis was performed using R. 
Data and Code Availability 
BLaER1 RNA-Seq data can be accessed at Gene Expression Omnibus (GEO: GSE138913) or at 
Sequence Read Archive (SRA: SRP225808). 
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